Aumed, a.s., Komořanská 326/63, 143 14 Praha - Modřany, Česká republika

info@aumed.cz+420 603 587 701 English

NEWS

PCR GARGLING KIT

07. 05. 2021

AUMED, a.s. launches its own self-sampling set based on the principle of gargling of the oral cavity and pharynx. The...

AUMED a.s. received support for the production of a diagnostic kit for covid-19

13. 12. 2020

AUMED a.s. received support for the project PRODUCTION OF DIAGNOSTIC KIT FOR COVID-19 ON THE LAMP PRINCIPLE within the TECHNOLOGY...

New sampling set GARGTEST

30. 11. 2020

AUMED, a.s. collaborated on the development of a new self-sampling set based on the principle of gargling of the oral...

“COVID-19” TESTING FOR COMPANIES

22. 10. 2020

AUMED a.s. offers for companies a comprehensive solution for preventive testing of the SARS-CoV-2 virus (COVID-19). We provide sampling and...

Covid-19 diagnostics using a newly developed test – AUMED test RT-LAMP Assay SARS-CoV-2

01. 10. 2020

AUMED a.s. is involved in the fight against the Covid-19 pandemic. In cooperation with Protean s.r.o. and Institute of Molecular and...

Successful completion of the OPPIK project ” Transfer factor – research and development of a new dosage form of immunotherapeutic medicinal product “

31. 08. 2020

This year, company AUMED a.s. successfully completed a multi-year project of the OPPIK program entitled “Transfer factor – research and...

Successful completion of the OPPIK project “RESEARCH AND DEVELOPMENT OF A NEW WHOLE-CELL VACCINE AGAINST WHOOPING COUGH”

31. 08. 2020

This year, company AUMED a.s. successfully completed a multi-year project of the OPPIK program entitled “RESEARCH AND DEVELOPMENT OF A...

Achievements in current grants

02. 12. 2019

The project of innovative vaccine against whooping cough is in the terminal phase. The priority is the research and development...

Pharmaceutical production

12. 11. 2019

AUMED is preparing the production of a mass-produced medical product. Under the contract manufacturing regime, AUMED wants to become a...

Research and development of a new oral administration of the vaccine in the company AUMED, a.s.

21. 10. 2019

As part of the 4th public tender in the TRIO program, AUMED has a project for a new version of...

Research projects of Aumed, a.s. are financed by the European Structural Funds:
Research and development of a new pertussis vaccine
Transfer factor — research and development of a new medical form
Production of diagnostic kit for covid-19 on the lamp principle

and with financial support from the state budget through the Ministry of Industry and Trade in the TRIO program:
Research and development of a new oral administration of vaccine

European Union
European Regional Development Fund
OP Enterprise and Innovation for Competitiveness


Tel.: +420 603 587 701, Email: info@aumed.cz
Komořanská 326/63, 143 14 Praha - Modřany, Česká republika
(c) 2017, Aumed a.s